Astellas Pharma Inc. (ALPMF)
OTCMKTS · Delayed Price · Currency is USD
12.23
0.00 (0.00%)
Dec 5, 2025, 4:00 PM EST
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of $23.2 billion as of December 9, 2025. Its market cap has increased by 17.19% in one year.
Market Cap
23.20B
Enterprise Value
26.11B
Revenue
13.56B
Ranking
n/a
PE Ratio
27.50
Stock Price
$12.23
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 6.96B to 23.20B, an increase of 233.25%. That is a compound annual growth rate of 3.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 23.05B | 31.90% |
| Dec 30, 2024 | 17.48B | -18.50% |
| Dec 29, 2023 | 21.44B | -22.67% |
| Dec 30, 2022 | 27.73B | -7.87% |
| Dec 30, 2021 | 30.10B | 5.02% |
| Dec 30, 2020 | 28.66B | -10.92% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 561.91M |
| Glass House Brands | 513.14M |
| CytoDyn | 403.93M |
| American Oncology Network | 365.47M |
| Northwest Biotherapeutics | 363.73M |
| Silence Therapeutics | 328.75M |
| Nika Pharmaceuticals | 259.91M |